CRIS Current Research Information System

ZANELLO, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.452
AS - Asia 2.470
EU - Europa 2.349
AF - Africa 201
SA - Sud America 114
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.421
SG - Singapore 730
CN - Cina 666
VN - Vietnam 608
GB - Regno Unito 505
DE - Germania 475
IT - Italia 288
SE - Svezia 256
HK - Hong Kong 171
UA - Ucraina 159
IN - India 154
FI - Finlandia 131
FR - Francia 123
RU - Federazione Russa 109
NL - Olanda 86
IE - Irlanda 82
BR - Brasile 78
CI - Costa d'Avorio 66
TG - Togo 46
KR - Corea 42
ZA - Sudafrica 38
EE - Estonia 36
JP - Giappone 32
SC - Seychelles 30
BG - Bulgaria 23
CA - Canada 23
AR - Argentina 21
CH - Svizzera 20
JO - Giordania 17
BE - Belgio 13
IR - Iran 13
ES - Italia 12
NG - Nigeria 11
AT - Austria 8
ID - Indonesia 7
MX - Messico 7
PL - Polonia 7
IQ - Iraq 6
BD - Bangladesh 5
EC - Ecuador 5
UZ - Uzbekistan 4
AU - Australia 3
CZ - Repubblica Ceca 3
MA - Marocco 3
PE - Perù 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
NP - Nepal 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
CG - Congo 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GF - Guiana Francese 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
MY - Malesia 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
UY - Uruguay 1
Totale 8.590
Salva come PNG Salva come JPEG
Città #
Singapore 480
Southend 442
Fairfield 413
Ashburn 381
Chandler 338
Munich 204
Dong Ket 202
Woodbridge 179
Hong Kong 171
Seattle 168
Wilmington 164
Houston 160
Santa Clara 143
Cambridge 132
Helsinki 109
Hefei 108
Princeton 108
Jacksonville 105
Ann Arbor 97
Ho Chi Minh City 89
Dublin 82
Beijing 77
Hanoi 74
Abidjan 66
Boardman 64
Dallas 62
Nanjing 57
Bologna 56
Los Angeles 48
Westminster 47
Lomé 46
Padova 43
Seoul 42
New York 38
Berlin 34
Tokyo 32
San Diego 31
Dearborn 29
Jinan 28
Buffalo 25
Milan 25
Delhi 24
Saint Petersburg 24
Frankfurt am Main 23
Sofia 23
Falkenstein 19
Turin 19
Des Moines 18
Amman 17
Bern 17
Da Nang 17
Florence 17
Mülheim 16
Shanghai 16
Shenyang 16
Guangzhou 15
Nanchang 15
Brussels 13
Redondo Beach 13
São Paulo 13
Haiphong 12
Mahé 12
Turku 12
Düsseldorf 11
Hebei 11
Mountain View 11
Redwood City 11
Tianjin 11
Abeokuta 10
Chicago 10
London 10
Toronto 10
Yubileyny 10
Ha Long 9
Olalla 9
Zhengzhou 9
Changsha 8
Verona 8
Bengaluru 7
Brooklyn 7
Chennai 7
Hải Dương 7
Jyväskylä 7
Kerkrade 7
Monmouth Junction 7
Ningbo 7
Biên Hòa 6
Falls Church 6
Jiaxing 6
Phoenix 6
Qingdao 6
Quận Bình Thạnh 6
Redmond 6
Thái Nguyên 6
Vienna 6
Borello 5
Haikou 5
Johannesburg 5
Lanzhou 5
Leawood 5
Totale 5.853
Salva come PNG Salva come JPEG
Nome #
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis b-and c-related-hepatocellularcarcinoma 406
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 315
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy 259
A new liver transplant priority for patients with hepatocellular carcinoma. 236
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 235
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 220
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 199
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 196
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 193
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 192
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 190
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 187
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 185
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 185
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 183
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 175
Matricellular proteins and survival in patients with pancreatic cancer: A systematic review 175
Using Elderly Donors in Liver Transplantation. 174
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 171
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 168
Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review 168
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 160
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 160
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 159
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 151
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 150
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 149
Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. 148
The role of liver resections for metastases from lung carcinoma. 146
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 145
The role of liver resections for metastases from lung carcinoma 144
Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation. 144
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 142
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. 139
The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. 133
Sirolimus in liver transplant recipients: a large single-center experience. 132
Hepatitis B virus and hepatitis C virus infections and risk of pancreatic ductal adenocarcinoma 130
Prospective down-staging protocol for HCC not meeting the Milan criteria 125
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry 123
Nested stromal-epithelial tumor (NSET) of the liver: A case report of an extremely rare tumor. 123
Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? 117
Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation. 113
Improved diagnostic imaging and interventional therapies prolong survival after resection for hepatocellular carcinoma in cirrhosis: the university of bologna experience over 10 years. 113
Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy 110
Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC 110
Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. 109
The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer 109
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 108
Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience 99
Use of vascular clamping in hepatic surgery: lessons learned from 1260 liver resections. 98
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries 92
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery 80
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC – B and – C: an Italian multicentric analysis 74
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 67
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 62
Correction: Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry (Surgical Endoscopy, (2023), 10.1007/s00464-023-09937-4) 55
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario 47
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 27
Robotic vs laparoscopic resection for hepatocellular carcinoma: multicentric propensity-score matched analysis of surgical and oncologic outcomes in 647 patients 7
Totale 8.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021539 0 0 0 0 0 38 21 49 50 35 46 300
2021/20221.005 105 43 58 76 88 52 19 68 29 43 256 168
2022/20231.220 110 198 64 167 59 103 31 89 223 24 99 53
2023/2024308 25 58 15 34 32 54 20 20 6 14 16 14
2024/20251.674 48 182 91 162 205 129 170 105 83 138 61 300
2025/20261.731 400 240 275 217 392 207 0 0 0 0 0 0
Totale 8.712